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( Supplementary Fig. 11 ) and satisfactory parameter recovery of the modes of the fitted parameter distributions for each participant ( Supplementary Fig. 12 ).
Behavioural analysis of AB trials
We carried out an additional analysis on AB trials to examine medication-or disease-related differences in AB choice behaviour associated with receiving either positive or negative feedback.
Data were separated into trials in which positive feedback was received on the previous trial of that pair (for regression 1) and trials in which negative feedback was received on the previous trial (for regression 2). These were divided into separate subsets since including a regressor for each of them in the same GLM would lead to rank deficiency (i.e. one is (necessarily) a linear combination of the other). We carried out a mixed-effects logistic regression analysis on each subset. In regression 1, the dependent variable (DV) was a binary indicator for choosing A (DV=1) or choosing B (DV=0) on the current trial. The first independent variable (IV1) coded for whether the A (optimal) or B (suboptimal) stimulus was chosen on the previous trial (IV1 = 1 or -1, respectively). In this way, a large positive beta estimate from the regression represented choosing A on the previous trial, receiving positive feedback, and choosing A again on the next trial. Medication and disease status were included as covariates, as in the other mixed-effects regressions, along with a varying subject intercept to account for individual differences. In regression 2 (trials following negative feedback), we used the same DV and covariates, but with IV1 coding the opposite sign to that in regression 1, i.e., choosing optimal A (IV1= -1) and choosing suboptimal B (IV1=1) on the previous trial. This inversion of sign means that a large positive beta estimate from the regression captured choosing B on the previous trial, receiving negative feedback, and switching to the optimal A stimulus on the next trial. For trials following positive feedback (regression 1), we found a main effect of IV1 (β (SE) = 0.84 (0.05), z = 17.33, p <.001), i.e. in general, participants stuck with the optimal A stimulus if rewarded for that choice on the previous trial. For trials following negative feedback, we found a large effect of medication (β (SE) = 0.52 (0.13), z = 3.96, p <.001), with a trend effect of disease (β (SE) = 0.64 (0.33), z = 1.95, p = .051) and IV_1 (β (SE) = −0.17 (0.09), z = 1.92, p = .055). The main effect of medication shows that in trials following negative feedback, PD ON chose the optimal A stimulus more often than PD OFF, regardless of what they chose in the previous trial. This suggests that, for the AB pair at least, PD ON were less inclined to use negative feedback to influence subsequent choice behaviour.
Session order effects
Experimental sessions were performed twice on PD patients and once on HCs. PD ON/OFF medication status was counterbalanced across first/second session in patients, so any session order effects on performance would be expected only in relation to HCs. We therefore carried out additional analyses on the behavioral data of the learning and transfer phases, to include session ("Sess") as a separate binary covariate in the mixed effects regression analyses reported in the Methods and materials section. We coded this as Sess=0 for HC since they only had one session, with Sess=0 for a patient's first session and Sess=1 for a patient's second session. The interaction between this variable and stimulus pair was also included, with the rest of the regression set up as in Equation 5 in manuscript.
For the learning phase, the effects already reported in the manuscript were also significant after carrying out this analysis; there was a main effect of stimulus pair (β (SE) = 0.37 (0.04), z = 8.75, p << .001), medication (β (SE) = 0.14 (0.04), z = 3.41, p < .001), an interaction between medication and stimulus pair (β (SE) = 0.21 (0.05), z = 4.27, p <.001), and an interaction between disease and stimulus pair (β (SE) = 0.18 (0.06), z = 3.11, p=.002) (see Supplementary Fig. 3A ). This analysis revealed an additional interaction between session and stimulus pair (β (SE) = −0.11 (0.05), z = 2.30, p=.02), which suggests that when patients were in their second session, the difference in accuracy between the AB and EF pair was smaller than when participants were in their first session.
There were no interactions between session and medication or disease.
For the transfer phase, the previously reported significant effects were again present; there was an interaction between medication (PD ON or OFF) and Approach A/Avoid B trial type (β (SE) = 0.35 (0.06), z = 5.78, p < .001) and an interaction between disease (HC or PD OFF) and Approach A/Avoid B trial type (β (SE) = 0.30 (0.07), z = 4.25, p < .001) (see Supplementary Fig. 3B ). There was also a main effect of session (β (SE) = -0.13 (0.06), z = 2.15, p = .03), with patients in their second session performing worse in general than participants in their first session. There were no interactions between session and medication or disease.
fMRI preprocessing
The following information was generated from FMRIPREP based on the preprocessing pipeline used in this study. Each T1w (T1-weighted) volume was corrected for INU (intensity non-uniformity) using N4BiasFieldCorrection v2.1.0 (Tustison et al., 2010) and skull-stripped using antsBrainExtraction.sh v2.1.0 (using the OASIS template). Brain surfaces were reconstructed using recon-all from FreeSurfer v6.0.1 (Dale et al., 1999) , and the brain mask estimated previously was refined with a custom variation of the method to reconcile ANTs-derived and FreeSurfer-derived segmentations of the cortical gray-matter of Mindboggle (Klein et al., 2017) . Spatial normalization to the ICBM 152 Nonlinear Asymmetrical template version 2009c (Fonov et al., 2009 ) was performed through nonlinear registration with the antsRegistration tool of ANTs v2.1.0 (Avants et al., 2008) , using brain-extracted versions of both T1w volume and template. Brain tissue segmentation of cerebrospinal fluid (CSF), white-matter (WM) and gray-matter (GM) was performed on the brainextracted T1w using fast (Zhang et al., 2001 ) (FSL version 5.0.9). Functional data was motion corrected using mcflirt (FSL version 5.0.9) (Jenkinson et al., 2002) ."Fieldmap-less" distortion correction was performed by co-registering the functional image to the same-subject T1w image with intensity inverted (Huntenburg et al., 2012; Wang et al., 2017) constrained with an average fieldmap template (Treiber et al., 2016) , implemented with antsRegistration (ANTs). This was followed by coregistration to the corresponding T1w using boundary-based registration (Greve and Fischl, 2009) with 9 degrees of freedom, using bbregister (FreeSurfer version 6.0.1). Slice timing correction was not performed on the data. Motion correcting transformations, field distortion correcting warp, BOLD-to-T1w transformation and T1w-to-template (MNI) warp were concatenated and applied in a single step using antsApplyTransforms (ANTs version 2.1.0) using Lanczos interpolation.
Physiological noise regressors were extracted applying CompCor (Behzadi et al., 2007) . Principal components were estimated for the two CompCor variants: temporal (tCompCor) and anatomical (aCompCor). A mask to exclude signal with cortical origin was obtained by eroding the brain mask, ensuring it only contained subcortical structures. Six tCompCor components were then calculated including only the top 5% variable voxels within that subcortical mask. For aCompCor, six components were calculated within the intersection of the subcortical mask and the union of CSF and WM masks calculated in T1w space, after their projection to the native space of each functional run.
Frame-wise displacement (Power et al., 2014) was calculated for each functional run using the implementation of Nipype. Many internal operations of FMRIPREP use Nilearn (Abraham et al., 2014) , principally within the BOLD-processing workflow. For more pipeline details, please refer to https://fmriprep.readthedocs.io/en/latest/workflows.html.
Single-trial whole-brain analysis
We were interested in estimating trial-by-trial representations of learning (e.g. RPEs) in the brain. For this, we carried out a single-trial whole-brain analysis to capitalize on the variability in BOLD signal across trials, using Nipype's FSL interface (Gorgolewski et al., 2011 (Gorgolewski et al., , 2017 . A Least Squares All (LSA) GLM was fit to each subject's brain data, per learning run (see Mumford et al., 2012) . The feedback onset of each trial was included as a separate regressor, all in one model. We included 13 confound regressors to remove nuisance effects that might have contributed to the brain signal:
Framewise Displacement (FD), 6 rigid-body transform motion parameters (3 translational, 3 rotational), and 6 aCompCor physiological noise regressors (to help exclude physiological noise in the CSF and WM). Spatial smoothing was performed using a Gaussian kernel with a full width at half maximum of 4 mm. A Savitsky-Golay filter was used for high-pass filtering, with a window length of 120 seconds and polynomial order of 3. The first-level design was set up using the Nipype interface to FMRI Expert Analysis Tool (FEAT) from FSL (FMRIB's Software Library, www.fmrib.ox.ac.uk/fsl).
Delta functions of all regressors in the model were convolved with the canonical hemodynamic response function (HRF) and regressed against each subject's fMRI data, using Nipype's FSL FILMGLS interface. From this, a contrast of parameter estimates (COPE) was obtained for each trial of every subject. Next, we performed a second-stage analysis on the single-trial copes, to model per trial feedback valence and RPE. The feedback regressor was coded as +1 or -1 for positive and negative feedback trials respectively, to model brain activity that co-varied with valence. A single RPE covariate regressor was constructed by taking the per-trial RPE (retaining its positive or negative sign), de-meaning this distribution across trials, and convolving these events with the HRF. Since feedback valence and RPE are correlated, i.e. positive feedback is accompanied by a positive RPE, this allowed us to assign brain activity co-varying specifically with valence or RPE. This was run as a fixed effects multiple regression model using FLAMEO on a per subject basis. Fixed effects multiple regression models for collapsing across runs and deriving within-patient medication difference COPEs were carried out in a similar way. Medication difference COPEs of feedback and RPE were then brought to the group level in a random effects model, using FSL's FLAME 1+2 and outlier detection procedures. All group level Z (Gaussianized T) statistic images were thresholded using clusters of z > 2.3 and a cluster-corrected significance threshold of p < 0.01. Group-level analyses were carried out in this way for each regressor (feedback valence and RPE) on each separate group (HC, PD ON, PD OFF), on the within-subject medication differences ON > OFF and OFF > ON, and on across-subject disease differences HC vs PD (OFF or ON). All group-level z-statistic contrasts can be viewed at https://doi.org/10.6084/m9.figshare.6989024.v2. The MNI152_T1_1mm_brain standard brain was converted to functional space using FSL FLIRT, eroded by 1 voxel, and used as a brain mask for all of the analyses described above.
ROIs
We obtained high-resolution probabilistic atlas masks from a recent open-source dataset (Pauli et al., 2018) . These sub-cortical ROIs have been well-established in playing an important role in reinforcement learning (Schultz et al., 1997; Brown et al., 1999; Hazy et al., 2010; O'Doherty et al., 2017) . We focused on striatal ROIs (caudate nucleus, putamen, and nucleus accumbens) for the learning phase deconvolution analysis, as these have been most extensively studied in the past (Frank, 2005; Cools et al., 2007; Cox et al., 2015; Jahfari et al., 2018) . FSL FLIRT was used to register the masks to FMRIPREP output space. BOLD percent signal change during the transfer phase was extracted from ROIs informed by the learning phase of the task. We took the cluster-corrected RPE medication difference (OFF-ON) z-statistic COPE from the learning phase and multiplied it by independent striatal ROIs from the Pauli et al. (2018) dataset. These masks were thresholded to exclude the lowest 25% of voxels and then binarized. The masks are available on figshare, at: https://doi.org/10.6084/m9.figshare.6989024.v2.
Deconvolution analysis of feedback interval and RPEs
Deconvolution analyses were carried out on BOLD timeseries from striatal ROIs (see ROIs for mask information). We extracted BOLD time courses and teased apart the covariation with BOLD signal of positive and negative RPEs separately, using the fMRI timeseries data as preprocessed by FMRIPREP. A Savitsky-Golay filter was used for high-pass filtering, with a window length of 120 seconds and polynomial order of 3. These timeseries were then converted to percent signal change (PSC). PSC was calculated by dividing the timeseries by the mean of the entire timeseries, multiplying by 100, and then subtracting 100, to get a mean-centered output timeseries. Data from each subject were weighted per voxel according to the probability of belonging to a particular striatal ROI, and then averaged across voxels of that ROI. We set up a model with three regressors: stimulus onsets (with RT duration), positive feedback onsets and negative feedback onsets. Positive and negative RPEs were z-scored separately and included as covariates of their respective positive or negative feedback event type. The deconvolution was implemented using the Python-based nideconv package (de Hollander and Knapen, 2017) . Events and covariates were deconvolved with a Fourier basis set, which uses a combination of sines and cosines to model the data. This was implemented instead of the standard finite impulse response (FIR) function as it substantially reduces the number of regressors, thereby improving the robustness of parameter estimates. Five Fourier regressors (1 intercept, 2 sine waves and 2 cosine waves) were used for each of the positive and negative feedback events and positive and negative RPE covariates. We also included several confound regressors in the model: FD, 6 rigid-body transform motion parameters (3 translational, 3 rotational), WM, stdDVARS (standardized derivative of RMS variance over voxels), and 6 aCompCor physiological noise regressors. Time courses were then estimated simultaneously using a least-squares fit, for the time window -2 to 13.05 seconds (7 TRs) around feedback onsets. Up-sampling during the fitting procedure was implemented 20-fold as part of nideconv functionality. The resulting time courses were then brought to the group level, and within-patient medication differences were calculated per upsampled timepoint of each fit. Clusters of significant intervals were identified using permutationbased one-sample t-tests (t-threshold set at p<.05, n=5000 permutations) as implemented in mnepython (version 0.15.2; (Gramfort et al., 2013 (Gramfort et al., , 2014 . Shaded regions in Fig. 4 and Supplementary   Fig. 8 represent 68% confidence intervals (±1 SEM; bootstrapped using n=5000 permutations). Supplementary Fig. 7 represent 95% confidence intervals (±1 SEM; bootstrapped using n=5000 permutations), to make group differences clearly visible.
Shaded regions in

Deconvolution analysis of choice interval and Q-values
We established a separate deconvolution analysis to assess modulations of the BOLD signal by Qvalues during the choice period, i.e. while the stimulus options were presented. We set up this model with the same three regressors as in the previous analysis: stimulus onsets (with RT duration), positive feedback onsets and negative feedback onsets, all with a Fourier basis set. However, here the Qvalues of the chosen stimulus were z-scored and entered as a covariate on the stimulus onset events.
RPEs were not included in the model. All other aspects of the analysis were the same as those described previously.
Applying the analysis to striatal ROIs, we did not find a significant medication-related difference in the caudate nucleus or nucleus accumbens. However, the analysis did reveal a significant PD ON > OFF difference in modulation of the BOLD signal by Q-values in the putamen (see Supplementary Fig. 9 ).
Transfer phase BOLD percent signal change
A standard GLM was set up to model BOLD responses to events in the transfer phase. Stimulus onsets and durations for three regressors were included: Approach A trials, Approach B trials, and all other trials (of no interest). Similar to the steps carried out in the learning phase whole-brain analysis, we performed 4mm smoothing, Savitsky-Golay high-pass filtering with a window length of 120 seconds and polynomial order of 3, and included the same 13 confound regressors in the design and convolved with a canonical HRF. Fixed effects analyses were performed across runs and for medication differences within patients. We then took the resulting two COPES for Approach A and Avoid B trials per subject and used FSL's featquery to calculate the mean percent signal change in the striatal ROIs that showed a significant learning phase medication difference in RPE (described in ROIs). In a similar way to the behavioral correlation analysis between learning rate and transfer accuracy (see Materials and Methods and Fig. 5B ), we included learning rate EVs to explain the PSC (OFF>ON) medication difference in Avoid B>Approach A trials in striatal ROIs using robust (multiple) regression, with EVs as either: both positive and negative learning rate medication differences (kαgain and kαloss), kαgain only, or kαloss only. Models were compared based on calculated BIC values (see Supplementary Table 4 ), and the learning to transfer PSC correlation p-value was obtained from the winning αloss-only model. Individual medication differences were quantified as the modes of the within-subject medication difference parameter distributions. Supplementary Figure 1 | Beta parameter estimates in learning phase mixed-effects logistic regression model, with choice accuracy as the dependent variable. PD OFF was considered as 'baseline', with any relative increase in beta parameters for PD ON or HC representing the effect of medication and disease status, respectively. Here, the main effects of disease and medication on choice accuracy are presented (left), as well as interaction effects of stimulus pair and disease, and stimulus pair and medication, on choice accuracy (right). Group-level parameter estimate distributions. Similar to other studies using separate learning rates for positive and negative events, we found higher learning rates for positive compared to negative feedback, termed "optimism bias" (Lefebvre et al., 2017; Jahfari et al., 2018; Van Slooten et al., 2018) . B) Simulation of the fitted model. To check whether the model sufficiently captured actual choice behavior of participants, we simulated the probability of choosing the best option using the posterior distributions of the fitted free parameters of each participant. Plots of the modeled against empirical data across each group and stimulus pair show that the model is a good representation of overall learning. C) Final Q-values across each stimulus and group from the fitted model, showing that the model did a good job in capturing declining Q-value according to decreasing reward contingency.
Supplementary Figures
Supplementary Figure 3 | Behavioral performance based on experimental session order in patients (not dopamine medication manipulation). See accompanying Supplementary
Information: Session order effects. PD patients performed the task twice (ON or OFF medication, counterbalanced across first/second session). HC performed the task once; HC results here are the same as in manuscript Fig. 1 and Fig. 5A. A) Learning phase accuracy per group in choosing the better option of each stimulus pair. B) Transfer phase accuracy per group in correctly choosing the best A stimulus when it is presented and correctly avoiding the worst B stimulus when it is presented. . Although no medication difference in RPE was found for ventral striatal NAc activity, it was included here for informational purposes since it has been implicated in several previous studies on the effects of dopamine on learning (Breiter et al., 2001; McClure et al., 2003; O'Doherty et al., 2003; Cools et al., 2007) . In NAc, there appears to be a quantitative PD ON > OFF group level difference in positive RPE, however this difference is not statistically significant when within-subject differences were cluster-corrected across multiple timepoints. Positive and negative RPEs in each ROI were z-scored around that ROI's BOLD response for positive and negative events, respectively. Colored bands represent 68% confidence intervals (±1 SEM). Supplementary Fig. 2A. (B) Individual-(session-) level correlations, using the modes of individual parameter distributions. (C, D) Parameter correlations between full posteriors of disease-and medication-difference distributions, respectively. These evaluations show that the parameters used in the model are only weakly related (Pearson r < .4) and indicates that these parameters can capture different aspects of the observed behaviour during learning. (Wilson et al., 1997) . The Complex Figure of Rey (CFR) was used as a measure of visuospatial memory. Verbal memory was assessed using the Dutch version of the Rey Auditory Verbal Learning Test (AVLT), testing both short-and long-term verbal memory (Saan and Deelman, 1986) . Digit span forwards and backwards in short form (WAIS) was used to assess working memory. Participants also completed several self-report questionnaires: Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Monetary Choice Questionnaire (MCQ). PD patients additionally completed the Wearing-Off Questionnaire (WOQ-Q10; related to the wearing off of DA medication), and the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS). The motor part of the Unified Parkinson's Disease Rating Scale (UPDRS III) was carried out before each fMRI session. An overview of several test scores is provided in the table below. These assessments were not examined in the current study but are discussed in greater detail elsewhere (Engels et al., 2018a, b) .
Supplementary
Quantities are presented as the mean across the sample, with brackets denoting 1 standard deviation. In order to compare the validity of the reported model with three free parameters αgain, αloss, and β, we evaluated two additional hierarchical Bayesian models and used the leaveone-out cross-validation information criterion (LOOIC) procedure for model comparisons. LOOIC is highly recommended for model comparisons of hierarchical Bayesian structures that use MCMC sampling . All models were set up in the same fully hierarchical way as the model shown in the manuscript (Model 2), either in a reduced form (Model 1) to include only two free base parameters (α and β), i.e. with a learning rate that is updated on every trial regardless of a positive or negative outcome, or in extended form (Model 3) to include one additional perseverance ("stickiness") parameter (π), to account for any bias in choosing the same stimulus of a pair regardless of the reward outcome (Kable and Glimcher, 2007; Schönberg et al., 2007) . π was included in the softmax equation and was bounded as [-5, 5] in accordance with previous research using this parameter (Wunderlich et al., 2012) . A lower LOOIC score indicates a better-fitting model. LOOIC estimates pointwise out-of-sample prediction accuracy from a fitted Bayesian model using the loglikelihood evaluated at the posterior simulations of the parameter values and may be extracted using the "loo" package in R (Gelman et al. 2013 , Yao et al., 2017 , Ahn et al. 2017 . The log-likelihoods were calculated per subject in the Stan model using the log categorical probability mass function. This was updated on a trial-by-trial basis to reflect whether a trial was correct given the probability of choosing that option. These log-likelihoods were then extracted from the fitted model on a per subject basis and used to calculate the LOOIC. Model 2 with three free parameters αgain, αloss, and β (as presented in the manuscript) was found to be the best fitting model. Supplementary Table 4 | Summary of BIC values for the role of medication-related shifts in learning rate parameters in subsequent medication-related changes in transfer phase behavior and BOLD activity. BIC values relating to transfer phase behavior (second column) describe the explanatory power of within-patient medication-related shifts in learning rate parameters (kαgain, kαloss) in the transfer phase medication-related interaction in approach/avoidance behavioral accuracy. BIC values relating to brain activity (third column) describe the explanatory power of the same within-patient medication-related shifts in learning rate parameters in the transfer phase medication-related interaction in caudate nucleus BOLD activity during approach versus avoid trials. Overall, in both brain and behavior, the medication-related shift in only the negative learning rate, αloss, parameter best explained subsequent medication-related changes in approach/avoidance trials. Supplementary Table 5 | Summary of learning phase PD medication differences in posterior distributions of the Bayesian model group parameters. Bayes factors (BF) for medication differences in learning parameter distributions represent the BF according to direction of the visible shift in the posterior difference, i.e., the αloss parameter in Fig. 2B is shifted to the left (higher OFF medication), so the BF represents the probability of OFF > ON being greater than zero. HDI = highest density interval. 
